Elevated levels of antibodies against HDL and ApoA1 have been reported in patients with cardiovascular disease (CVD), and are significantly higher in patients with SLE, the levels of which were negatively correlated with the activity of paraoxonase (PON) (78). Here, APOA1 is linked to systemic lupus erythematosus.